2Koob GF,Le Moal M.Drug addiction,dysregulation of reward,and allostasis [J].Neuropsychopharmacology,2001,24(2):97-129.
3Kelley AE,Berridge KC.The neuroscience of natural rewards:relevance to addictive drugs[J].J Neurosci,2002,22(9):3306-3311.
4Manzanedo C,Aguilar MA,Minarro J.The effects of dopamine D2and D3 antagonisists on spontaneous motor activity and morphine-induced hyperactivity in male mice[J].Psychophacology(Berl),1999,143(1):82-88.
5Laviolette SR,Nader K,van der Kooy D.Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes[J].Behav Brain Res,2002,129(1-2):17-29.
8Tomkins DM,Sellers EM.Addiction and the brain:the role of neurotransmitters in the cause and treatment of drug dependence[J].CMAJ,2001,164(6):817-821.
9Torres G,Horowitz JM.Drugs of abuse and brain gene expression[J].Psychosomatic Med,1999,61(5):630-650.
6[1]Zahm DS, Brog JS, On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience, 1992,50:751～767
7[2]Pennartz CM, Groenewegen HJ, Lopes da Sliva FG. The nu cleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioral, electrophysiological and anatomical data. Prog Neurobiol, 1994,42:719～761
8[3]Koob GF. Drug of abuse: anatomy, pharmacology and function of reward pathways. TIPS, 1992,13:177～184
9[4]White NM, Packard MG, Hiroi N. Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nu cleus accumbens. Psychopharmacology, 1987,103: 271 ～ 281
10[5]Geoders NE, Lane JD, Smith JE. Self-administration of me thionine-enkephalin into the nucleus accumbens. Pharmacol Biochem Behav, 1984,20:451～457
